Fig 4 - by Maryann S. Watson (16879881)

Subjects:

Species counts for all trap (kubben) catches across sites and seasons. by Maryann S. Watson (16879881)

Subjects:

Fig 5 - by Maryann S. Watson (16879881)

Subjects:

Species counts per catch for all fyke catches across sites and seasons. by Maryann S. Watson (16879881)

Subjects:

Fig 2 - by Maryann S. Watson (16879881)

Subjects:

Species and numbers of individuals caught on reef-cages and in reference traps. by Maryann S. Watson (16879881)

Subjects:

Fig 1 - by Maryann S. Watson (16879881)

Subjects:

Forest plot of the effect of high-dose TXA on operation time. by Xin Liu (43569)

Subjects:

Lists of differentially expressed genes under high night-time temperatures with and without 1-MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Lists of differentially expressed genes under high night-time temperatures without 1-MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Lists of differentially expressed genes under ambient night-time temperatures with and without 1-MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Lists of differentially expressed genes for the interaction between high night-time temperature and 1-MCP treatments. by Wardah K. Mustahsan (17484456)

Subjects:

DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

“…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …”

DIP coding logic example. by Chenxuan Zhu (22622476)

“…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …”

DIP pre-payment and provider behavior mechanism. by Chenxuan Zhu (22622476)

“…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …”

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…In contrast, BCVA in the non-recurrence group significantly improved from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 over the same time points (Kruskal–Wallis test, P < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”

ROS reduces the expression of Akt3, WDR12 and Aurora B leading to micronuclei. by Zachary J. Hough (20840430)

Subjects:

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects: